Enter your email address below and we will send you a link to reset your password:
New developments are emerging regarding the health condition of actor Ufuk Özkan, who is awaiting a liver transplant and undergoing treatment in the hospital. While the search for a suitable donor continues during his treatment, his celebrity friends are not leaving him alone during this challenging period. The latest condition of Ufuk Özkan, who was visited by figures like Rojda Demirer, Mehtap Bayri, and Hamdi Alp, has been shared with the public.
Ufuk Özkan's brother, Umut Özkan, provided information about his brother's general health, stating that the test results have not yet turned positive. His friends, who frequently visit Ufuk Özkan as he continues his life in the hospital, are providing him with moral support. After being visited by his co-stars from the series Geniş Aile previously, names like Rojda Demirer and Mehtap Bayri have now offered their support. These visits contribute to keeping Ufuk Özkan's spirits high.
During the visits, it was observed that Ufuk Özkan had become quite thin, but his morale was reported to be good. The actor's brother, Umut Özkan, stated that Ufuk Özkan is receiving additional nutritional supplements, milk, and serum support to help him gain weight and maintain his strength. It has been reported that Özkan is able to eat and his general condition is stable. While the hopeful wait for a liver transplant continues, the support from the art community is of great importance to Ufuk Özkan.
The condition of Ufuk Özkan, who is awaiting a liver transplant, is being closely followed by his loved ones. According to the statements from his brother Umut Özkan, the actor's treatment process is ongoing, and the search for a suitable donor continues. While prayers are being offered for Ufuk Özkan's recovery, the visits from his artist friends also give him strength during this period. Ufuk Özkan's overall health and his response to treatment will become clearer in the coming days.
Comments
Login Required
No comments yet. Be the first to comment!